Site Search

... With North Carolina passing Medicaid Expansion and CON being part of the debate, we might have an opportunity in Georgia in 2024.  Access to Biomarker Testing : ACS CAN successfully advocated for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

... contributions to the fight against cancer and leadership on the successful passage of first-in-the-nation legislation for comprehensive biomarker testing. "A longtime and established champion of health care issues, Leader Flowers again took on a leading role to help ensure cancer patients can ... of cancer-related public policy advocacy. "For Illinoisans with serious diseases like cancer, Leader Flowers knew that we must improve access to biomarker testing to make sure they are receiving the best treatment possible," said Shana Crews, ACS CAN government relations director. "Leader ...

... is asking the legislature to prioritize access to care for cancer patients through the expansion of telehealth services and increased access to biomarker testing. Telehealth is critical because it provides cancer patients and survivors with a convenient means of accessing some cancer care and primary ... ‘the right treatment, to the right patient, at the right time,’ precision medicine plays a critical role in improving cancer outcomes, and biomarker testing is an essential step to precision medicine. Legislative action on these pieces of legislation would improve access to care for ...

... insurance can find themselves with medical debt. The problem for these patients is that their insurance may not cover medically appropriate testing and treatments. This forces many New Jerseyans to choose between their physical and financial health. For example, some health insurance plans may not cover the biomarker testing that a patient needs. This testing is a game-changer in the fight against cancer and an essential step in accessing precision ... looking to change that and increase access to this revolutionary testing by requiring state-regulated health plans, including Medicaid, to cover biomarker testing for patients who can benefit. “As we pursue the aforementioned opportunities to assist current patients, we must also consider ...